The speakers from our January panel discussion on immunogenicity answer further questions from the live event
We present a rare opportunity to see experts from across the pharmaceutical and CRO industries sharing perspectives on FDA guidance, transitioning skills and future hopes for the bio lab.
Webinar available to view on demand. In this case study, Alturas Analytics (ID, USA) presents the techniques they use in their labs for optimal analysis of large molecules from biological matrices.
Thank you everyone who attended our live webinar ‘Clinical relevance of (unwanted drug induced) immune responses’. Here are some responses to the questions posed during the live event that we did not have time to answer.
Webinar available to view on demand. In this free panel discussion, our experts will provide insights into their own research with immunogenicity including the challenges they have had to overcome, key trends they have seen and their future outlook of the development of this field.
Webinar available to view on demand. Exploring the challenges a lack of industry standardization presents for CRO project managers and scientists as well as biopharma and biotech companies.
Webinar available to view on demand. This webinar will give an overview of immunogenicity assay development, explore the impact of anti-drug antibodies on bioanalysis and review relevant case studies discussing in-study cut-point and tolerance.
Webinar available to view on demand. Learn how a standardized approach for the bioanalysis of biotherapeutics by hybrid LC–MS is applied in a contract research environment, whilst also considering compliance with regulatory requirements.
Webinar available to view on demand. Methods for the detection of drug-induced antibodies have become much more sensitive, but the question remains to be answered: are antibodies at this low concentration level clinically relevant?
Webinar available to view on demand. In this webinar, our Bioanalysis Zone Rising Star Award winner, Jing Tu (PPD; VA, USA), will introduce a systematic approach that allows efficient and consistent ligand binding based bioanalytical method development.
Webinar available to view on demand. This webinar talks about the benefit of incorporating microsampling techniques in bioanalytical assays, as well as the effort required to overcome the challenges.
Researchers have developed a new diagnostic technique to accurately differentiate bladder cancer from benign inflammation using AHNAK2 protein biomarkers.
In this short article one of the organisers of the 23rd International Reid Bioanalytical Forum, Tim Sangster, discusses what this year’s conference has in store from scientific content to social activities.
We talk to Vellalore Kakkanaiah about his work using flow cytometry in adoptive cell therapy in this interview as part of our author’s perspective series.
Join us for our Twitter chat with proteomics experts on Friday 22nd February at 15:00 [GMT], 10:00 [EST], where we will discuss the applications of proteomics, mass spectrometry techniques and the challenges of proteomics research #TalkProteomics.
This editorial provides an insight into the advancing field of microsampling as a tool to monitor critically ill patients in the clinic, highlighting the need for further development to ensure patients receive the highest quality of care.